Exercise mitigates diclofenac-induced liver mitochondrial dysfunction

European Journal of Clinical Investigation

Volumn 44, Issue 7, 2014, Pages 668-677

  Santos Alves, Estela ^a   Marques Aleixo, Ines ^a   Coxito, Pedro ^a,b   Balça, Maria M ^a   Rizo Roca, David ^c   Rocha Rodrigues, Silvia ^a   Martins, Sandra ^a,d   Torrella, Joan R ^c   Oliveira, Paulo J ^b   Moreno, Antonio J ^e   Magalhães, José ^a   Ascensão, António ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF BARCELONA   (Spain)

^d HOSPITAL DE SÃO JOÃO   (Portugal)

^e UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Apoptotic signalling; Bioenergetics; Exercise; Liver toxicity; Nonsteroid anti inflammatory drugs; Oxidative stress

Indexed keywords

ACONITATE HYDRATASE; CASPASE 3; CASPASE 8; CASPASE 9; DICLOFENAC; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PROTEIN BAX; PROTEIN BCL 2; SIRTUIN 3; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BIOLOGICAL MARKER; NEUROTOXIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREATHING; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRIC POTENTIAL; ENDURANCE TRAINING; ENZYME ACTIVITY; EXERCISE; IN VITRO STUDY; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER PROTECTION; MALE; MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RAT; SEDENTARY LIFESTYLE; TRANSMISSION ELECTRON MICROSCOPY; VOLUNTARY ACTIVITY; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; LIVER MITOCHONDRION; METABOLISM; MITOCHONDRIAL DISEASES; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; DICLOFENAC; MALE; MEMBRANE POTENTIALS; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA, LIVER; MITOCHONDRIAL DISEASES; NEUROTOXINS; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PHYSICAL CONDITIONING, ANIMAL; RATS, SPRAGUE-DAWLEY; RESPIRATION;

EID: 84903397449     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12285     Document Type: Article

References (42)

1. Xu JJ, Henstock PV, Dunn MC, Smith AR, Chabot JR, de Graaf D. Cellular imaging predictions of clinical drug-induced liver injury. Toxicol Sci 2008;105:97-105.
2. Masubuchi Y, Nakayama S, Horie T. Role of mitochondrial permeability transition in diclofenac-induced hepatocyte injury in rats. Hepatology 2002;35:544-51.
3. Gomez-Lechon MJ, Ponsoda X, O'Connor E, Donato T, Castell JV, Jover R. Diclofenac induces apoptosis in hepatocytes by alteration of mitochondrial function and generation of ROS. Biochem Pharmacol 2003;66:2155-67.
4. Lal N, Kumar J, Erdahl WE, Pfeiffer DR, Gadd ME, Graff G et al. Differential effects of non-steroidal anti-inflammatory drugs on mitochondrial dysfunction during oxidative stress. Arch Biochem Biophys 2009;490:1-8.
5. Masubuchi Y, Yamada S, Horie T. Diphenylamine as an important structure of nonsteroidal anti-inflammatory drugs to uncouple mitochondrial oxidative phosphorylation. Biochem Pharmacol 1999;58:861-5.
6. Petrescu I, Tarba C. Uncoupling effects of diclofenac and aspirin in the perfused liver and isolated hepatic mitochondria of rat. Biochim Biophys Acta 1997;1318:385-94.
7. Siu WP, Pun PB, Latchoumycandane C, Boelsterli UA. Bax-mediated mitochondrial outer membrane permeabilization (MOMP), distinct from the mitochondrial permeability transition, is a key mechanism in diclofenac-induced hepatocyte injury: Multiple protective roles of cyclosporin A. Toxicol Appl Pharmacol 2008;227:451-61.
8. Gauthier MS, Couturier K, Charbonneau A, Lavoie JM. Effects of introducing physical training in the course of a 16-week high-fat diet regimen on hepatic steatosis, adipose tissue fat accumulation, and plasma lipid profile. Int J Obes Relat Metab Disord 2004;28:1064-71.
9. Johnson NA, George J. Fitness versus fatness: moving beyond weight loss in nonalcoholic fatty liver disease. Hepatology 2010;52:370-81.
10. Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006;6:1-28.
11. Goncalves IO, Oliveira PJ, Ascensao A, Magalhaes J. Exercise as a therapeutic tool to prevent mitochondrial degeneration in nonalcoholic steatohepatitis. Eur J Clin Invest 2013;43:1184-94.
12. Ascensao A, Goncalves IO, Lumini-Oliveira J, Marques-Aleixo I, Dos Passos E, Rocha-Rodrigues S et al. Endurance training and chronic intermittent hypoxia modulate in vitro salicylate-induced hepatic mitochondrial dysfunction. Mitochondrion 2012;12:607-16.
13. Ascensao A, Martins MJ, Santos-Alves E, Goncalves IO, Portincasa P, Oliveira PJ et al. Modulation of hepatic redox status and mitochondrial metabolism by exercise: therapeutic strategy for liver diseases. Mitochondrion 2013;13:862-70.
14. Rector RS, Thyfault JP. Does physical inactivity cause nonalcoholic fatty liver disease? J Appl Physiol 2011;111:1828-35.
15. Ascensao A, Magalhaes J, Soares JM, Ferreira R, Neuparth MJ, Marques F et al. Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis. Am J Physiol Heart Circ Physiol 2005;289:H722-31.
16. Coore HG, Denton RM, Martin BR, Randle PJ. Regulation of adipose tissue pyruvate dehydrogenase by insulin and other hormones. Biochem J 1971;125:115-27.
17. Ascensao A, Lumini-Oliveira J, Machado NG, Ferreira RM, Goncalves IO, Moreira AC et al. Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats. Clin Sci (Lond) 2011;120:37-49.
18. Estabrook RW. Mitochondrial respiratory control and the polarographic measurement of ADP/O ratios. Methods Enzymol 1967;10:41-7.
19. Broekemeier KM, Dempsey ME, Pfeiffer DR. Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem 1989;264:7826-30.
20. Vicencio AG, Muzumdar H, Tsirilakis K, Kessel A, Nandalike K, Goldman DL. Severe asthma with fungal sensitization in a child: response to itraconazole therapy. Pediatrics 2010;125:e1255-8.
21. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-10.
22. Hu ML. Measurement of protein thiol groups and GSH in plasma. In: Parker L, editor. Methods in Enzymology. San Diego: CA: Academic; 1990: pp 380-5.
23. Lumini-Oliveira J, Magalhaes J, Pereira CV, Moreira AC, Oliveira PJ, Ascensao A. Endurance training reverts heart mitochondrial dysfunction, permeability transition and apoptotic signaling in long-term severe hyperglycemia. Mitochondrion 2011;11:54-63.
24. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
25. Locke M, Noble EG, Atkinson BG. Exercising mammals synthesize stress proteins. Am J Physiol 1990;258:C723-9.
26. Chang Q, Miao X, Ju X, Zhu L, Huang C, Huang T et al. Effects of pulse current on endurance exercise and its anti-fatigue properties in the hepatic tissue of trained rats. PLoS ONE 2013;8:e75093.
27. Botezelli JD, Mora RF, Dalia RA, Moura LP, Cambri LT, Ghezzi AC et al. Exercise counteracts fatty liver disease in rats fed on fructose-rich diet. Lipids in health and disease 2010;9:116.
28. Fontaine E, Eriksson O, Ichas F, Bernardi P. Regulation of the permeability transition pore in skeletal muscle mitochondria. Modulation By electron flow through the respiratory chain complex i. J Biol Chem 1998;273:12662-8.
29. Boveris A, Navarro A. Systemic and mitochondrial adaptive responses to moderate exercise in rodents. Free Radic Biol Med 2008;44:224-9.
30. Little JP, Safdar A, Benton CR, Wright DC. Skeletal muscle and beyond: the role of exercise as a mediator of systemic mitochondrial biogenesis. Appl Physiol Nutr Metab 2011;36:598-607.
31. Kowaltowski AJ, Castilho RF, Vercesi AE. Mitochondrial permeability transition and oxidative stress. FEBS Lett 2001;495:12-5.
32. Di Lisa F, Bernardi P. A CaPful of mechanisms regulating the mitochondrial permeability transition. J Mol Cell Cardiol 2009;46:775-80.
33. Verdin E, Hirschey MD, Finley LW, Haigis MC. Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem Sci 2010;35:669-75.
34. Li X, Kazgan N. Mammalian sirtuins and energy metabolism. Int J Biol Sci 2011;7:575-87.
35. De Marchi E, Baldassari F, Bononi A, Wieckowski MR, Pinton P. Oxidative stress in cardiovascular diseases and obesity: role of p66Shc and protein kinase C. Oxid Med Cell Longev 2013;2013:564961.
36. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005;122:221-33.
37. Zoratti M, Szabo I, De Marchi U. Mitochondrial permeability transitions: how many doors to the house? Biochim Biophys Acta 2005;1706:40-52.
38. Hafner AV, Dai J, Gomes AP, Xiao CY, Palmeira CM, Rosenzweig A et al. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging (Albany NY) 2010;2:914-23.
39. Kincaid B, Bossy-Wetzel E. Forever young: SIRT3 a shield against mitochondrial meltdown, aging, and neurodegeneration. Front Aging Neurosci 2013;5:48.
40. Goncalves IO, Passos E, Rocha-Rodrigues S, Torrella JR, Santos-Alves E, Portincasa P et al. Physical exercise antagonizes clinical and anatomical features characterizing Lieber-DeCarli diet-induced obesity and related metabolic disorders. Clin Nutr 2014; doi: 10.1016/j.clnu.2014.03.010. [Epub ahead of print].
41. Goncalves IO, Passos E, Rocha-Rodrigues S, Diogo CV, Torrella JR, Rizo D et al. Physical exercise prevents and mitigates non-alcoholic steatohepatitis-induced liver mitochondrial structural and bioenergetics impairments. Mitochondrion 2014;15:40-51.
42. Oliveira PJ. Mitochondria as a drug target in health and disease. Curr Drug Targets 2011;12:761.